Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Lehtinen, Markus J ^a   Hibberd, Ashley A ^a   Männikkö, Sofia ^b   Yeung, Nicolas ^a   Kauko, Tommi ^b   Forssten, Sofia ^a   Lehtoranta, Liisa ^a   Lahtinen, Sampo J ^a   Stahl, Buffy ^a   Lyra, Anna ^a   Turner, Ronald B ^c  

^a DUPONT COMPANY   (United States)

^b ElectroCity   (Finland)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BACTERIUM; BIODIVERSITY; CLASSIFICATION; CLUSTER ANALYSIS; CONTROLLED STUDY; FECES; HUMAN; INFLAMMATION; METABOLISM; MICROBIOLOGY; MICROFLORA; NOSE; PATHOLOGY; PHYSIOLOGY; PICORNAVIRUS INFECTION; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

BACTERIA; BIODIVERSITY; BIOMARKERS; CLUSTER ANALYSIS; FECES; HUMANS; INFLAMMATION; MICROBIOTA; NOSE; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; VIRAL LOAD; YOUNG ADULT;

EID: 85050822671     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-29793-w     Document Type: Article

References (48)

1. Byington, C. L. et al. Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis 61, 1217–1224, 10.1093/cid/civ486 (2015)
2. Turner, R. B. Rhinovirus. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases Vol. 2 (eds J. E. Bennett, R. Dolin, & M. J. Blaser) Ch. 177, 2113–2121 (Elsevier, 2015)
3. Proud, D. Upper airway viral infections. Pulmonary Pharmacology & Therapeutics 21, 468–473 (2008)
4. Barrett, B., Brown, R., Voland, R., Maberry, R. & Turner, R. Relations among questionnaire and laboratory measures of rhinovirus infection. European Respiratory Journal 28, 358–363 (2006)
5. Heinonen, S. et al. Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis. American journal of respiratory and critical care medicine 193, 772–782, 10.1164/rccm.201504-0749OC (2016)
6. Zaas, A. K. et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6, 207–217, 10.1016/j.chom.2009.07.006 (2009)
7. Kitazawa, H. & Villena, J. Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505. Front Immunol 5, 201, 10.3389/fimmu.2014.00201 (2014)
8. Budden, K. F. et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol 15, 55–63, 10.1038/nrmicro.2016.142 (2017)
9. McAleer, J. P. & Kolls, J. K. Maintaining poise: commensal microbiota calibrate interferon responses. Immunity 37, 10–12, 10.1016/j.immuni.2012.07.001 (2012)
10. Wu, S. et al. Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection. Curr Microbiol 67, 414–422, 10.1007/s00284-013-0380-z (2013)
11. Hasegawa, K. et al. The Fecal Microbiota Profile and Bronchiolitis in Infants. Pediatrics 138, 10.1542/peds.2016-0218 (2016)
12. Bassis, C. M. et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio 6, e00037, 10.1128/mBio.00037-15 (2015)
13. Lemon, K. P. et al. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio 1, 10.1128/mBio.00129-10 (2010)
14. Hasegawa, K. et al. Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-Control Study. Pediatr Infect Dis J, 10.1097/INF.0000000000001500 (2016)
15. Hasegawa, K. et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J 48, 1329–1339, 10.1183/13993003.00152-2016 (2016)
16. Rosas-Salazar, C. et al. Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk. American journal of respiratory and critical care medicine 193, 1180–1183, 10.1164/rccm.201512-2350LE (2016)
17. de Steenhuijsen Piters, W. A. et al. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. American journal of respiratory and critical care medicine 194, 1104–1115, 10.1164/rccm.201602-0220OC (2016)
18. Hao, Q., Dong, B. R. & Wu, T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2, CD006895, 10.1002/14651858.CD006895.pub3 (2015)
19. Hill, C. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506–514, 10.1038/nrgastro.2014.66 (2014)
20. Garcia-Crespo, K. E. et al. Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection. Antiviral Res 97, 270–279 (2013)
21. Youn, H.-N. et al. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res 93, 138–143 (2012)
22. van Baarlen, P. et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA 108(Suppl 1), 4562–4569, 10.1073/pnas.1000079107 (2011)
23. West, N. P. et al. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin Nutr 33, 581–587, 10.1016/j.clnu.2013.10.002 (2014)
24. Turner, R. B. et al. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial. Benef Microbes 8, 207–215, 10.3920/BM2016.0160 (2017)
25. Huse, S. M., Ye, Y., Zhou, Y. & Fodor, A. A. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS One 7, e34242, 10.1371/journal.pone.0034242 (2012)
26. Johansen, H. K. & Hoiby, N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47, 109–111 (1992)
27. Psoter, K. J., De Roos, A. J., Wakefield, J., Mayer, J. & Rosenfeld, M. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect 19, E483–489, 10.1111/1469-0691.12272 (2013)
28. Ramos, G. P., Rocha, J. L. & Tuon, F. F. Seasonal humidity may influence Pseudomonas aeruginosa hospital-acquired infection rates. Int J Infect Dis 17, e757–761, 10.1016/j.ijid.2013.03.002 (2013)
29. Bonecchi, R. et al. Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed) 14, 540–551 (2009)
30. Blander, J. M., Longman, R. S., Iliev, I. D., Sonnenberg, G. F. & Artis, D. Regulation of inflammation by microbiota interactions with the host. Nat Immunol 18, 851–860, 10.1038/ni.3780 (2017)
31. Maciejewski, B. A. et al. Rhinovirus-bacteria coexposure synergistically induces CCL20 production from human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 312, L731–L740, 10.1152/ajplung.00362.2016 (2017)
32. Kanmani, P. et al. Respiratory Commensal Bacteria Corynebacterium pseudodiphtheriticum Improves Resistance of Infant Mice to Respiratory Syncytial Virus and Streptococcus pneumoniae Superinfection. Front Microbiol 8, 1613, 10.3389/fmicb.2017.01613 (2017)
33. Spurrell, J. C., Wiehler, S., Zaheer, R. S., Sanders, S. P. & Proud, D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289, L85–95, 10.1152/ajplung.00397.2004 (2005)
34. Mansbach, J. M. et al. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol 137, 1909–1913 e1904, 10.1016/j.jaci.2016.01.036 (2016)
35. Rosas-Salazar, C. et al. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy. J Infect Dis 214, 1924–1928, 10.1093/infdis/jiw456 (2016)
36. Hendley, J. O., Hayden, F. G. & Winther, B. Weekly point prevalence of Streptococcus pneumoniae, Hemophilus influenzae and Moraxella catarrhalis in the upper airways of normal young children: effect of respiratory illness and season. APMIS 113, 213–220, 10.1111/j.1600-0463.2005.apm1130310.x (2005)
37. Chaban, B. et al. Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza. PLoS One 8, e69559, 10.1371/journal.pone.0069559 (2013)
38. Allen, E. K. et al. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome 2, 22, 10.1186/2049-2618-2-22 (2014)
39. Hofstra, J. J. et al. Changes in microbiota during experimental human Rhinovirus infection. BMC Infect Dis 15, 336, 10.1186/s12879-015-1081-y (2015)
40. Kawahara, T. et al. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model. Microbiol Immunol 59, 1–12, 10.1111/1348-0421.12210 (2015)
41. Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6, 1621–1624, 10.1038/ismej.2012.8 (2012)
42. Chao, A. & Bunge, J. Estimating the number of species in a stochastic abundance model. Biometrics 58, 531–539 (2002)
43. Faith, D. P. Conservation evaluation and phylogenetic diversity. Biological Conservation 61, 1–10 (1992)
44. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71, 8228–8235, 10.1128/AEM.71.12.8228-8235.2005 (2005)
45. Wickham, H. ggplot2: Elegant Graphics for Data Analysis. (Springer-Verlag, 2009)
46. Turner, R. B., Weingand, K. W., Yeh, C.-H. & Leedy, D. Association between nasal secretion interleukin-8 concentration and symptom severity in experimental rhinovirus colds. Clinical Infectious Diseases 26, 840–846 (1998)
47. Turner, R. B. et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection. Journal of the American Medical Association 281, 1797–1804 (1999)
48. Barrett, B. et al. The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid. Journal of Clinical Epidemiology 58, 609–617 (2005)